Northeast Financial Consultants Inc Eli Lilly & CO Transaction History

Northeast Financial Consultants Inc

$2.25 Billion
Q3 2024

A detailed history of Northeast Financial Consultants Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 9,932 shares of LLY stock, worth $7.37 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

9,932

Previous 9,835 0.99%

Holding current value

$7.37 Million

Previous $8.9 Million 1.18%

% of portfolio

0.39%

Previous 0.41%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$772.14 - $960.02 $74,897 - $93,121	97 Added 0.99%	9,932 $8.8 Million
Q2 2024 Aug 15, 2024	BUY	$724.87 - $909.04 $40,592 - $50,906	56 Added 0.57%	9,835 $8.9 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $2.17 Million - $2.9 Million	3,662 Added 59.87%	9,779 $7.61 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $651,760 - $768,340	1,241 Added 25.45%	6,117 $3.57 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $158,665 - $218,744	365 Added 8.09%	4,876 $2.62 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $11 Million - $14.7 Million	-31,343 Reduced 87.42%	4,511 $2.12 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $4,038 - $4,742	13 Added 0.04%	35,854 $12.3 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $168,170 - $195,952	523 Added 1.48%	35,841 $13.1 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $202,495 - $230,765	-683 Reduced 1.9%	35,318 $11.4 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $365,136 - $428,723	1,310 Added 3.78%	36,001 $11.7 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $13,377 - $16,624	57 Added 0.16%	34,691 $9.93 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $10,193 - $12,544	46 Added 0.13%	34,634 $8 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $36,110 - $46,708	200 Added 0.58%	34,588 $7.94 Million
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $11,079 - $12,932	-100 Reduced 0.29%	34,388 $3.81 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $165,851 - $195,219	-1,490 Reduced 4.14%	34,488 $4.48 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $3.81 Million - $4.27 Million	35,978 New	35,978 $4.16 Million

Others Institutions Holding LLY

# of Institutions

4,028

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $705B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Account

Northeast Financial Consultants Inc Eli Lilly & CO Transaction History